CPAP, weight loss, or both for obstructive sleep apnea.

ABSTRACT:

Background

Obesity and obstructive sleep apnea tend to coexist and are associated with inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal relation to these abnormalities is unclear.

Methods

We randomly assigned 181 patients with obesity, moderate-to-severe obstructive sleep apnea, and serum levels of C-reactive protein (CRP) greater than 1.0 mg per liter to receive treatment with continuous positive airway pressure (CPAP), a weight-loss intervention, or CPAP plus a weight-loss intervention for 24 weeks. We assessed the incremental effect of the combined interventions over each one alone on the CRP level (the primary end point), insulin sensitivity, lipid levels, and blood pressure.

Results

Among the 146 participants for whom ther

SUBMITTER: Chirinos JA 

PROVIDER: S-EPMC4138510 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature